Why is Nectar Lifesci. falling/rising?

As of 08-Jul, Nectar Lifescience Ltd is experiencing a significant decline in its stock price, currently at Rs. 18.53, reflecting a decrease of 4.63 (-19.99%). The stock has hit a new 52-week low today and has underperformed its sector by 19.06%. It opened with a loss of 4.36% and reached an intraday low of Rs. 18.53. The stock has shown high volatility with an intraday volatility of 15.93% and is trading below all its moving averages. The company's financial health is concerning, with operating losses and a high Debt to EBITDA ratio of 5.71 times, indicating a weak ability to service its debt. The recent quarterly profit after tax has fallen drastically by 3160.9%, and the stock has generated a return of -40.36% over the past year, further highlighting its poor performance.
In the broader market context, the stock's short-term return of -18.91% over the past week contrasts sharply with the Sensex, which has remained relatively stable with a slight increase of 0.02%. This underperformance is compounded by the fact that 99.6% of promoter shares are pledged, adding downward pressure in a declining market. The stock's liquidity appears adequate for trading, but the overall sentiment remains negative due to the company's weak long-term fundamentals and significant losses.